Ralph D'Agostino to Myocardium
This is a "connection" page, showing publications Ralph D'Agostino has written about Myocardium.
Connection Strength
0.368
-
Jordan JH, Sukpraphrute B, Meléndez GC, Jolly MP, D'Agostino RB, Hundley WG. Early Myocardial Strain Changes During Potentially Cardiotoxic Chemotherapy May Occur as a Result of Reductions in Left Ventricular End-Diastolic Volume: The Need to Interpret Left Ventricular Strain With Volumes. Circulation. 2017 06 20; 135(25):2575-2577.
Score: 0.135
-
Jordan JH, Vasu S, Morgan TM, D'Agostino RB, Meléndez GC, Hamilton CA, Arai AE, Liu S, Liu CY, Lima JA, Bluemke DA, Burke GL, Hundley WG. Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors. Circ Cardiovasc Imaging. 2016 08; 9(8).
Score: 0.127
-
Willis MS, Parry TL, Brown DI, Mota RI, Huang W, Beak JY, Sola M, Zhou C, Hicks ST, Caughey MC, D'Agostino RB, Jordan J, Hundley WG, Jensen BC. Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle-Specific Ubiquitin Ligase MuRF1. Circ Heart Fail. 2019 03; 12(3):e005234.
Score: 0.038
-
Meléndez GC, Jordan JH, D'Agostino RB, Lesnefsky EJ, Hundley WG. Accelerated Left Ventricular Interstitial Collagen Deposition After Receiving Doxorubicin in Hypertension. J Am Coll Cardiol. 2018 09 25; 72(13):1555-1557.
Score: 0.037
-
Meléndez GC, Jordan JH, D'Agostino RB, Vasu S, Hamilton CA, Hundley WG. Progressive 3-Month Increase in LV Myocardial ECV After Anthracycline-Based Chemotherapy. JACC Cardiovasc Imaging. 2017 06; 10(6):708-709.
Score: 0.032